AI technology developed by Caristo Diagnostics was the focus of multiple studies presented at ESC Congress 2026.

Caristo Diagnostics, a global leader in AI technologies for cardiovascular disease, today announced new independent ...

STAREE trial will give its verdict on primary prevention statins in people ages 70 and up ...

If I may focus on my role as the European Society of Cardiology (ESC) President, we reorganised governance. The ESC is a huge ...

Medicare Advantage enrollees who developed a new complex condition, such as congestive heart failure or Alzheimer’s disease, were more likely to leave their plan for traditional Medicare the next year ...

As healthcare costs rise and access to doctors becomes increasingly difficult, many Nigerians are turning to unqualified ...

Discover how personalized mRNA tumor vaccines could revolutionize cancer treatment, building on recent melanoma trial ...

She was devastated to find out she'd need a third breast cancer surgery after the first two found positive margins. — (Chloë ...

The deepest lesson I have learned after performing 6,000 heart operations runs against the story our culture keeps telling ...

Experts in Germany, Austria, and Switzerland issued consensus recommendations for administering onasemnogene abeparvovec in ...

No, you do not need to bean-maxx.

A new investigational cancer vaccine developed by Merck & Co. and Moderna is customized based on the genome of each patient's ...